Recently, Jian et al. reported that GPR84 activation prevents osteolysis during bone metastases of CRC and that CRC cells cause downregulation of GPR84 expression on BMDMs, promoting osteoclastogenesis. This evidence concerns the gene GPR84 and colorectal carcinoma.